Kyoto University
Department of Early Clinical Development Graduate School of MedicineKyoto University HospitalDepartment of Early Clinical DevelopmentKyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT)
October 2021 to March 2024 Takeshi Sawada (Principal Investigator) is implementing the project (Japan Agency for Medical Research and Development)“Development of ex vivo safety/efficacy evaluation method for GPC-1 CAR T therapy for solid tumors”
Next Generation Medical and iPS Cell Therapy Research Center(Ki-CONNECT) Early Medical Development Department Assistant professor, Masahiko Aoki has been appointed.
December 2020 to March 2022 We conducted the following clinical trial. “A bioequivalence Study of an Anti-Cancer Drug in Healthy Volunteers”
Next Generation Medical and iPS Cell Therapy Research Center(Ki-CONNECT) Early Medical Development Department Assistant professor, Masaru Fukahori has been appointed.
June 2020 to March 2021 We conducted the following clinical trial “A Bioequivalence Study of a central Nervous System Acting Drug in Healthy Volunteers”
« 過去の投稿
新しい投稿 »